<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01472133</url>
  </required_header>
  <id_info>
    <org_study_id>11/LO/1667</org_study_id>
    <nct_id>NCT01472133</nct_id>
  </id_info>
  <brief_title>Validation of Respiration Rate Algorithms</brief_title>
  <official_title>Validation of Respiration Rate Algorithms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Engineering and Physical Sciences Research Council, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous accurate unobtrusive respiratory rate monitoring may lead to improved patient&#xD;
      outcomes, as respiratory rate is thought to be a sensitive marker of patient deterioration.&#xD;
      Currently systems are not suitable for long term monitoring, particularly in ambulant&#xD;
      patients as they are too restrictive. To ensure that our algorithms are suitable for use in a&#xD;
      clinical context we need to demonstrate their performance not only in the optimal situation,&#xD;
      healthy volunteers at rest, but also in more challenging situations such as where the person&#xD;
      being monitored is moving and also in patients who have conditions which may affect their&#xD;
      physiology in such a way that the accuracy of the respiration rate estimation may be&#xD;
      affected.&#xD;
&#xD;
      No previous study has systematically tested algorithms deriving respiratory rate from either&#xD;
      the ECG or the photoplethysmography (PPG) waveforms in a real -world setting.&#xD;
&#xD;
      The algorithms work by looking for changes in intervals between heartbeats and also changes&#xD;
      in the sizes of the ECG and PPG waveforms, both of which may be caused by respiration. These&#xD;
      changes tend to diminish with increasing age and also conditions which alter the chest&#xD;
      movement and cardiac reflexes. Thus it is important to test our algorithms' accuracy in&#xD;
      participants exhibiting these conditions. It is also important to ensure that the&#xD;
      calculations of respiratory rate are accurate across a range of heart rates and respiratory&#xD;
      rates. Our testing covers all these variables.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The coefficient of variation for each respiration rate algorithm</measure>
    <time_frame>5-6 months</time_frame>
    <description>The algorithms to be tested are:&#xD;
one which calculates respiration rate (RR) from ECG only, one which calculates RR from PPG only, one which calculates RR from simultaneous ECG and PPG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The coefficient of variation for the respiration rate calculated from a second pulse oximeter</measure>
    <time_frame>5-6 months</time_frame>
    <description>Participants will wear two different PPG monitors to assess whether PPG monitors from different manufacturers introduce artefactual changes to the PPG morphology</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Respiratory Rate</condition>
  <condition>Pulse Oximetry</condition>
  <arm_group>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
    <description>Healthy volunteers under the age of 40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <description>Healthy volunteers over the age of 70</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <description>Patients with permanent AF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <description>Patients who have an implanted pacemaker that is continually pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with restricted chest movement</arm_group_label>
    <description>Patients whose chest expansion is less than 2.5cm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of 12 lead ECG</intervention_name>
    <description>Recording of 12 lead ECG</description>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <arm_group_label>Patients with restricted chest movement</arm_group_label>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of lying and standing blood pressure</intervention_name>
    <description>Recording of lying and standing blood pressure</description>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <arm_group_label>Patients with restricted chest movement</arm_group_label>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of chest wall movement</intervention_name>
    <description>Recording of chest wall movement</description>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of heart rate variability</intervention_name>
    <description>Done during deep breathing and a valsalva manoeuvre</description>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <arm_group_label>Patients with restricted chest movement</arm_group_label>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of ECG and Pulse oximeter waveform at rest</intervention_name>
    <description>For 10 mins</description>
    <arm_group_label>Older healthy volunteers</arm_group_label>
    <arm_group_label>Patients with a pacemaker</arm_group_label>
    <arm_group_label>Patients with atrial fibrillation</arm_group_label>
    <arm_group_label>Patients with restricted chest movement</arm_group_label>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of ECG and Pulse oximeter waveform during exercise</intervention_name>
    <description>Recording of ECG and Pulse oximeter waveform during exercise</description>
    <arm_group_label>Young Healthy Volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers and hospital outpatients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Young Healthy Volunteers&#xD;
&#xD;
               -  Participant is willing and able to give informed consent for participation in the&#xD;
                  study.&#xD;
&#xD;
               -  Male or Female, aged between 18 and 40 years old.&#xD;
&#xD;
          -  Older Healthy Volunteers&#xD;
&#xD;
               -  Participant is willing and able to give informed consent for participation in the&#xD;
                  study.&#xD;
&#xD;
               -  Male or Female, aged 70 years or above.&#xD;
&#xD;
          -  Patients&#xD;
&#xD;
               -  Participant is willing and able to give informed consent for participation in the&#xD;
                  study.&#xD;
&#xD;
               -  Male or Female, aged 18-70 years old.&#xD;
&#xD;
               -  Participant has one of the following conditions:&#xD;
&#xD;
               -  Atrial fibrillation&#xD;
&#xD;
               -  A permanent pacemaker that is continuously active&#xD;
&#xD;
               -  Reduced chest wall movement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Young Healthy Volunteers&#xD;
&#xD;
               -  Any condition which might increase the risk of exercise testing&#xD;
&#xD;
               -  Any history of ischaemic heart disease&#xD;
&#xD;
               -  Any history of heart failure&#xD;
&#xD;
               -  Any structural heart disease (eg: valvular lesions, hypertrophic obstructive&#xD;
                  cardiomyopathy)&#xD;
&#xD;
               -  Any abnormalities on a resting ECG&#xD;
&#xD;
               -  Deep vein thrombosis diagnosed within the last 6 months or under active treatment&#xD;
&#xD;
               -  Uncontrolled hypertension (systolic blood pressure &gt;220 mm Hg, diastolic &gt;120 mm&#xD;
                  Hg)&#xD;
&#xD;
               -  Aortic aneurysm&#xD;
&#xD;
               -  Aortic or cardiovascular surgery within 6 months of recruitment&#xD;
&#xD;
               -  A family history of sudden cardiac death, congenital arrhythmia syndromes or&#xD;
                  cardiomyopathy&#xD;
&#xD;
               -  Autonomic dysfunction, either previously diagnosed or upon testing by the&#xD;
                  research team&#xD;
&#xD;
               -  Any condition involving the brain or spinal cord&#xD;
&#xD;
               -  Diabetes&#xD;
&#xD;
               -  Alcohol consumption &gt; 21 units/week for women and 28 units/week for men or a&#xD;
                  history of previous alcohol dependence.&#xD;
&#xD;
               -  Acute kidney injury&#xD;
&#xD;
               -  Chronic kidney disease stage 4 or 5&#xD;
&#xD;
               -  Any condition causing hepatic dysfunction&#xD;
&#xD;
               -  Presence of a permanent pacemaker (these participants would be eligible for the&#xD;
                  pacemaker group)&#xD;
&#xD;
               -  Reduced chest wall movement (these participants would be eligible for the reduced&#xD;
                  chest movement group)&#xD;
&#xD;
               -  Any acute infection requiring antibiotic treatment within 3 months of recruitment&#xD;
&#xD;
               -  Any other surgery or illness requiring hospitalisation within 3 months of&#xD;
                  recruitment&#xD;
&#xD;
               -  Currently taking any medication with the exception of analgesics or the oral&#xD;
                  contraceptive pill.&#xD;
&#xD;
               -  Any wound or skin condition affecting the torso which may be affected by the&#xD;
                  application of adhesive ECG dots to the skin&#xD;
&#xD;
               -  Pregnancy&#xD;
&#xD;
               -  Inability to give informed consent&#xD;
&#xD;
          -  Older Healthy Volunteers&#xD;
&#xD;
               -  Any diagnosed condition primarily affecting the cardiovascular or respiratory&#xD;
                  systems&#xD;
&#xD;
               -  Symptomatic autonomic dysfunction&#xD;
&#xD;
               -  Orthostatic hypotension&#xD;
&#xD;
               -  Any condition involving the brain or spinal cord&#xD;
&#xD;
               -  Diabetes&#xD;
&#xD;
               -  Alcohol consumption &gt; 21 units/week for women and 28 units/week for men or a&#xD;
                  history of previous alcohol dependence.&#xD;
&#xD;
               -  Acute kidney injury&#xD;
&#xD;
               -  Chronic kidney disease stage 4 or 5&#xD;
&#xD;
               -  Any condition causing hepatic dysfunction&#xD;
&#xD;
               -  Presence of a permanent pacemaker&#xD;
&#xD;
               -  Chronic Obstructive Pulmonary Disease (COPD).&#xD;
&#xD;
               -  Any muscular dystrophy&#xD;
&#xD;
               -  Kyphosis&#xD;
&#xD;
               -  Scoliosis&#xD;
&#xD;
               -  Pectus excavatum&#xD;
&#xD;
               -  Any disease involving the lungs or pleura&#xD;
&#xD;
               -  Any acute infection requiring antibiotic treatment within 3 months of recruitment&#xD;
&#xD;
               -  Any other surgery or illness requiring hospitalisation within 3 months of&#xD;
                  recruitment&#xD;
&#xD;
               -  Currently taking any medication with the exception of analgesics or the oral&#xD;
                  contraceptive pill.&#xD;
&#xD;
               -  Any wound or skin condition affecting the torso which may be affected by the&#xD;
                  application of adhesive ECG dots to the skin&#xD;
&#xD;
               -  Pregnancy&#xD;
&#xD;
               -  Inability to give informed consent&#xD;
&#xD;
          -  Patients&#xD;
&#xD;
               -  Any infection which would require isolation or barrier nursing according to the&#xD;
                  hospital's infection control policy&#xD;
&#xD;
               -  Any wound or skin condition affecting the torso which may be affected by the&#xD;
                  application of adhesive ECG dots to the skin&#xD;
&#xD;
               -  Requirement for any form of artificial ventilatory support, including oxygen&#xD;
                  therapy&#xD;
&#xD;
               -  More than one of the inclusion criteria. (ie: a patient may not have both atrial&#xD;
                  fibrillation and reduced chest wall movement and be eligible for this study)&#xD;
&#xD;
               -  Inability to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Beale, MBBS, FRCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <study_first_submitted>October 20, 2011</study_first_submitted>
  <study_first_submitted_qc>November 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2011</study_first_posted>
  <last_update_submitted>February 11, 2014</last_update_submitted>
  <last_update_submitted_qc>February 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guy's and St Thomas' NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Richard Beale</investigator_full_name>
    <investigator_title>Clinical Director</investigator_title>
  </responsible_party>
  <keyword>Respiration Rate</keyword>
  <keyword>ECG</keyword>
  <keyword>Pulse oximetry</keyword>
  <keyword>Photoplethysmograph</keyword>
  <keyword>PPG</keyword>
  <keyword>Physiology</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

